The British government should not get complacent about AstraZeneca’s U.S. listing, as it paves the way for a full one in New York.
CNBC’s UK Exchange newsletter: AstraZeneca gets a shot on Wall Street
Related Posts
Treasury Secretary Bessent says it’s up to China to de-escalate trade tensions
The comments come with markets on edge over the direction of tariffs.
Jina-ColBERT-v2 Released: A Groundbreaking Multilingual Retrieval Model Achieving 6.6% Performance Boost and 50% Storage Reduction Across Diverse Benchmarks
The field of information retrieval (IR) has rapidly evolved, especially with the integration of neural networks, which have transformed how…
Teaching Mistral Agents to Say No: Content Moderation from Prompt to Response
In this tutorial, we’ll implement content moderation guardrails for Mistral agents to ensure safe and policy-compliant interactions. By using Mistral’s…